Cited by 347Immunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.

Novel approaches for vaccine development

Open access

Gebre, Makda S., Brito, Luis A., Tostanoski, Lisa H., Edwards, Darin K., Carfi, Andrea, Barouch, Dan H.·2021·Cell

DOI 10.1016/j.cell.2021.02.030PMC PMC8049514

Open this paper in CoChat — free account Open PDF

Abstract

Vaccines are critical tools for maintaining global health. Traditional vaccine technologies have been used across a wide range of bacterial and viral pathogens, yet there are a number of examples where they have not been successful, such as for persistent infections, rapidly evolving pathogens with high sequence variability, complex viral antigens, and emerging pathogens. Novel technologies such as nucleic acid and viral vector vaccines offer the potential to revolutionize vaccine development as they are well-suited to address existing technology limitations. In this review, we discuss the current state of RNA vaccines, recombinant adenovirus vector-based vaccines, and advances from biomaterials and engineering that address these important public health challenges.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.02.030

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 3×
“Lipid nanoparticle mRNA delivery In contrast to naked mRNA, formulated mRNA has been shown to result in higher protein expression in vitro and more potent immune responses in vivo (Pollard et al., 2013; Wolff et al., 1990).”
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. M. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,166
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · cited 4×
“mRNA-1273 vaccine candidates, both encoding the SARS-CoV-2 pre-fusion stabilized S2P protein, which showed very high efficacy in Phase 3 trials (Baden et al., 2020a; Jackson et al., 2020; Mulligan et al., 2020; Polack et al., 2020).”
Influential
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419

Flagged first, then by citations

Show all 151 references

4 of the 151 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Goldstein, 2020, Safety and Immunogenicity of Heterologous and Homologous Two Dose Regimens of Ad26- and MVA-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study, J. Infect. Dis.
Mulligan, 2020, Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, Nature, 586, 589, 10.1038/s41586-020-2639-4 · DOI · Paper page
Sadoff, 2020, Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial, medRxiv

Sorted by citations

Items 201–300 of 347

Nanoparticle-Based Vaccines against Zoonotic Viruses: A Review
Zhang, X., & Cui, Z. (2023) · Zoonoses · doi:10.15212/zoonoses-2023-0018 · Cited by 6
A universal strategy of facilitating intracellular delivery of nanomedicines based on tuning ARF6 GTPase to its GTP-bound form
Song, S., Guo, X., Zhang, Z., Fan, S., Zhang, R., Yan, Z., Chen, Q., Song, Y., Wu, P., Wang, C., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101888 · Cited by 5
A extrafiscalidade e os controles de proporcionalidade e de igualdade
Papadopol, M. D. (2009) · Americanae (AECID Library) · Cited by 5
Mannose-decorated polymersomes loaded with antigens and TLR7/8 agonists targeting antigen-presenting cells for enhancing vaccine efficacy
Lim, J.-W., Lee, S.-E., Park, H., Lee, S., Yeom, M., Haam, S., & Song, D. (2025) · Materials Advances · doi:10.1039/d5ma00115c · Cited by 4
Novel Strategies for Developing Next-Generation Vaccines to Combat Infectious Viral Diseases
Yuan, F., & Bluth, M. H. (2025) · Vaccines · doi:10.3390/vaccines13090979 · Cited by 5
Biodistribution of mRNA vaccines in rats: Enrichment in injection site and lymph tissues and rapid clearance without tissue persistence
Goody, S. M. G., Rowbottom, C., Liu, Y., & Chen, N. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102948 · Cited by 5
Antigen-loaded flagellate bacteria for enhanced adaptive immune response by intradermal injection
Tao, F., Ye, Q., Chen, Y., Luo, L., Xu, H., Xu, J., Feng, Z., Wang, C., Li, T., Wen, Y., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.055 · Cited by 4
Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection
Martinot, A. J., Cox, F., Abbink, P., Hecht, J. L., Bronson, R. T., Borducchi, E. N., Rinaldi, W. J., Ferguson, M. J., Barrera, R. A. D. L., Zahn, R. C., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00927-8 · Cited by 4
Self-citation
Research Progress of Microneedles in Vaccine Delivery
Qiao, X., Liu, D., Pan, W., He, M., & Meng, F. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673336874241129081141 · Cited by 4
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques
Karaliota, S., Moussa, M., Rosati, M., Devasundaram, S., Sengupta, S., Goldfarbmuren, K. C., Burns, R., Bear, J., Stellas, D., Urban, E., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112232 · Cited by 4
Long noncoding RNA Nron and its functional motif modulate macrophage-mediated inflammatory response
Yang, L., Wang, P., Liu, K., Liu, B., Zhu, J., Li, F., Ai, M., Li, X., Liang, M., Huang, K., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.032 · Cited by 4
Recent advances in engineering approaches for delivery of mRNA-based therapeutics
Prinindya, K. N. N., Ashraf, G. M., Uddin, S., Mahdi, E., & Hasan, A. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214667 · Cited by 6
Exosome-based vaccines in cancer immunotherapy: antitumor mechanisms, engineering strategies, and challenges
Zhou, H., Shi, Y., Wang, Y., & Bai, G. (2026) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-026-06435-7 · Cited by 4
In Vivo miRNA Decoy Screen Reveals miR-124a as a Suppressor of Melanoma Metastasis
Moubarak, R. S., Koetz‐Ploch, L., Mullokandov, G., Gaziel, A., de Pablos-Aragoneses, A., Argibay, D., Kleffman, K., Sokolova, E., Berwick, M., Thomas, N. E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852952 · Cited by 4
Vaccines and sera
Sahu, G., Kumari, P., & Goyal, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91924-1.00009-5 · Cited by 5
Super epitope dengue vaccine instigated serotype independent immune protection in-silico
Naskar, S., Chandpa, H. H., Agarwal, S., & Meena, J. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.04.009 · Cited by 4
Vaccines for preventing infections in adults with haematological malignancies
Zorger, A.-M., Hirsch, C., Baumann, M., Feldmann, M., Bröckelmann, P. J., Mellinghoff, S. C., Monsef, I., Skoetz, N., & Kreuzberger, N. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015530.pub2 · Cited by 5
Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes
Ornelas, M. Y., Thomas, A. Y., Rosas, L., Scoville, R. O., & Mehta, A. P. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00359 · Cited by 4
Identifying Cross-Utilization of RSV Vaccine Inventions across the Human and Veterinary Field
Janse, M., Soekhradj, S., de Jong, R., & van de Burgwal, L. (2022) · Pathogens · doi:10.3390/pathogens12010046 · Cited by 4
Bioinspired Cellular Membrane Vesicles Derived from Bacterial and Erythrocyte Ghosts: Development and Applications as a Smart Drug Delivery System
Majid, A., Memon, N. H., Arain, S. Q., Channa, U., Ali, M., & Phull, A. R. (2024) · Nano LIFE · doi:10.1142/s1793984424410010 · Cited by 4
Biomimetic and Bioinspired Composite Processing for Biomedical Applications
Kumar, H., Justa, P., Jaswal, N., Pani, B., & Kumar, P. (2023) · Wiley eBooks · doi:10.1002/9781394166985.ch9 · Cited by 4
Designing multifunctional recombinant vaccines: an engineering strategy based on innovative epitope prediction-guided splicing
Wang, Z., Yang, X., Wei, X., Shi, L., Wang, X., Zhuo, Z., Su, H., Wu, W., & Cao, Y. J. (2025) · Theranostics · doi:10.7150/thno.103755 · Cited by 3
mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases
Tan, B. E. K., Tham, S. K., & Poh, C. L. (2025) · Viruses · doi:10.3390/v17070960 · Cited by 4
Method validation and assessment of the biodistribution and shedding for adenovirus vector-based vaccine using qPCR and dPCR
Tanaka, Y., Hamano, S., Ishii‐Watabe, A., Saito, Y., & Kikura‐Hanajiri, R. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101549 · Cited by 3
Lipid nanoparticle–based mRNA platforms for mucosal HIV vaccines: formulation advances, immune mechanisms, and translational pathways
Singh, N. S. S., Gataa, I. S., Saleh, L. H., Ganesan, S., Kavitha, V., Maharana, L., Sharma, R., Latipova, M., Madatova, N., Jumanazarov, D., et al. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04596-6 · Cited by 4
A cocktail vaccine with monkeypox virus antigens confers protection without selecting mutations in potential immune evasion genes in the vaccinia WR strain challenge
Sun, X., Zhang, L., Chen, G., Yang, F., Ning, X., Qiu, J., Gao, Y., Yang, J., Zhang, W., zhang, Z., et al. (2025) · mBio · doi:10.1128/mbio.03200-25 · Cited by 3
Bovine viral diarrhea virus vaccines: Current advancements, challenges, and future perspectives
Pang, F., Liang, S., & Zhou, W. (2026) · Virulence · doi:10.1080/21505594.2026.2645832 · Cited by 3
Microneedles Based Thermally Stable Ad‐5 Viral Vector for Vaccine Delivery
Singh, P., Sharma, N., Huang, F., Bhaskar, N., Akbaba, H., Park, J., Radhakrishnan, A., Sakhrie, A., Nguyen, L., Ge, G., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504342 · Cited by 3
Particulate Cell Wall Materials of Lactobacillus acidophilus as Vaccine Adjuvant
Lin, S.-C., Chang, P.-C., Lin, C.-H., Liang, H., & Huang, C. (2022) · Veterinary Sciences · doi:10.3390/vetsci9120698 · Cited by 3
Computational identification of membrane proteins for vaccine design against drug-resistant Moraxella catarrhalis
Arshad, F., Pervaiz, R., Sarfraz, A., Ejaz, H., Alotaibi, A., Ullah, R., Nishan, U., Ali, A., Khan, M. U., & Shah, M. (2025) · Molecular Genetics and Genomics · doi:10.1007/s00438-025-02288-w · Cited by 3
RNA Vaccines: The Evolution, Applications, and the Challenges Ahead
Banerji, I., Bhattacharjee, S., Mukherjee, K., & Bhattacharyya, S. N. (2023) · Springer eBooks · doi:10.1007/978-981-19-8520-1_10 · Cited by 3
Vaccines for the prevention of infections in adults with solid tumors
Zorger, A.-M., Hirsch, C., Kreuzberger, N., Bröckelmann, P. J., Mellinghoff, S. C., Monsef, I., & Skoetz, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015551 · Cited by 3
Stochastic Molecular Reaction Queueing Network Modeling for in Vitro Transcription Process
Wang, K., Xie, W., & Zheng, H. (2023) · Winter Simulation Conference · doi:10.1109/wsc60868.2023.10408139 · Cited by 3
Microneedle-mediated vaccine delivery
Nguyen, T. T., & Vo, G. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13881-2.00016-3 · Cited by 3
Alkyl chain engineering of ionic AIE molecules for developing superior self-adjuvanted nanovaccines in cancer immunotherapy
Chen, Y., Bao, Y., Wang, Y., Liu, J., Zheng, W., Chen, P., Wei, W., Ji, M., Zhang, R., Hou, P., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.159979 · Cited by 3
COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes
Fair-Mäkelä, R., Thorén, P., Näsiaho, J., Sundqvist, P., Piiroinen, I., Kähäri, L., Julkunen, I., Ivaska, J., Hub, E., Rot, A., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adr6787 · Cited by 4
Inflating the role of stromal cells in CD8+ T cell memory
Block, K. E., & Jameson, S. C. (2021) · Nature Immunology · doi:10.1038/s41590-021-00974-6 · Cited by 3
An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged micePreprint
Borriello, F., Nanishi, E., Seo, H., O’Meara, T. R., McGrath, M. E., Saito, Y., Haupt, R. E., Chen, J., Diray‐Arce, J., Song, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.09.459664 · Cited by 3
Self-citation
Predicting PROTAC-targeted Degradation and Designing Androgen Receptor Degraders with AiPROTACPreprint
Zhang, L., Sun, R., Li, X., Ren, C., Long, Y., Tan, W., Wang, X., Zou, K., Yang, X., Wu, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.26.640266 · Cited by 5
A candidate tick-borne encephalitis virus vaccine based on virus-like particles induces specific cellular and humoral immunity in mice
Zhang, M., Jin, H., Jiao, C., Zhang, Y., Bai, Y., Gong, Z., Huang, P., Zhang, H., Li, Y., & Wang, H. (2024) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2024.09.024 · Cited by 2
Flexible deformation and special interface structure in nanoparticle-stabilized Pickering bubbles strengthen the immunological response as adjuvant
Chen, Q., Teng, J., Zhu, C., Du, J., Wang, G., & Wu, J. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb01763c · Cited by 2
Evaluation of cylindrical micelles assembled from amphiphilic β-peptides as antigen delivery nanostructures
Martin, C., Côté‐Cyr, M., Nguyen, P. T., Archambault, D., & Bourgault, S. (2025) · Nanoscale Advances · doi:10.1039/d5na00166h · Cited by 2
Computer‐Aided Technology for Bioactive Protein Design and Clinical Application
Wang, C., Chen, Y., & Ren, L. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500007 · Cited by 2
Optimizing Immunization Strategies for Individuals Living with HIV: A Review of Essential Vaccines, Vaccine Coverage, and Adherence Factors
Würfel, L. M., Potthoff, A., Skaletz‐Rorowski, A., Nambiar, S., & Rached, N. A. (2025) · Vaccines · doi:10.3390/vaccines13080798 · Cited by 2
Innovations and challenges in vaccine development: Lessons from the SARS-CoV-2 pandemic and prospects
Mohammed, A., Ibrahim, N. A., & Basher, N. S. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152947 · Cited by 2
Design of antibody structure-guided epitope vaccines in silico to induce potent immune responses against emerging viruses
Wei, X., Zhao, L., Zhao, Z., Gong, Y., Zheng, Y., Cheng, G., Wang, G., Zhu, B., & Kong, W. (2025) · Journal of Virology · doi:10.1128/jvi.00689-25 · Cited by 2
A Comprehensive Review of Vaccine Development: From Traditional Platforms to Messenger RNA (mRNA) Technologies
Pawar, B. P. S., Loganathan, S., Belliappa, K. M., Ranganathan, L. B., Thekdi, K. P., & Hiware, S. D. (2026) · Cureus · doi:10.7759/cureus.100608 · Cited by 3
Paediatric Solid Tumour Vaccines: Current Processes, Prevailing Challenges and Future Perspectives
Liu, S., Yang, M., Xi, B., Wang, Y., Zhang, A., Liu, A., & Jin, H. (2026) · Immunology · doi:10.1111/imm.70105 · Cited by 2
Artificial intelligence and machine learning across vaccine lifecycle: a systematic review
Okesanya, O. J., Hassan, M. M., Adebayo, U. O., Ali, I., Ahmed, M. M., Oso, T. A., Othman, Z. K., Cue, E. G., Espinas, A. D., & Lucero‐Prisno, D. E. (2026) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2026.100379 · Cited by 2
A novel mRNA-based multiepitope vaccine candidate against Cryptosporidium hominis and Cryptosporidium parvum employing reverse-vaccinology and immunoinformatics approaches
Mahdeen, A. A., Hossain, I., Masum, M. H. U., Rabbi, T. M. F., & Islam, M. S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343643 · Cited by 2
Recent advances in LNP-mRNA vaccines
Redenti, B. J., Zhong, Y., Yu, C., & Dong, Y. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115675 · Cited by 3
Roadmap to the Development of mRNA Therapeutics: From Molecule Design and Delivery Strategies to Manufacturing, Quality Control, and Regulatory Considerations
Meyer, R. A., Trabulo, S. M. D., Douthwaite, J. A., & Santos, J. L. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_1 · Cited by 3
The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
An, Z., Zhang, Y., Yu, X., Jia Hui, X. I. A., Yin, Y., Li, G., Lu, J., Fan, X., & Xu, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051412 · Cited by 3
Biotechnological Tools – Advances and Diagnostics to Control Parasitic Diseases in Aquaculture
Devnath, S., Dhar, S., Verma, A., Kumar, V., Roy, S., Rout, A. K., Jana, A. K., & Behera, B. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-3165-7_7 · Cited by 2
Emerging Market Vaccine Manufacturers: Untapped Potential for Improving Health and Social Outcomes Globally
Hayman, B., & Petty, J. S. (2024) · Thunderbird International Business Review · doi:10.1002/tie.22409 · Cited by 2
The long road for vaccine development with difficulties and hopes
Ge, Q., Chen, P., Cheng, Y., & Xiao, Y. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2396886 · Cited by 2
The rational design of mRNA vaccine: From empirical method to artificial intelligence-based design
Hu, Y., Pu, C., Liu, B., & Zhang, L. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0478 · Cited by 2
Bioinformatics and immunoinformatics approaches in the design of a multi-epitope vaccine targeting CTLA-4 for melanoma treatment
Noor, F., Shahid, S., Fatima, M., Haider, S. Z., Shehri, Z. S. A., Alshehri, F. F., & Rehman, A. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11108-7 · Cited by 2
Antivirotics based on defective interfering particles: emerging concepts and challenges
Maryanchik, S. V., Borovikova, S. E., Ivanova, A. O., Trofimov, V. V., Bagrova, O. E., Frolova, A., Mityaeva, O. N., Volchkov, P., & Deviatkin, A. A. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1436026 · Cited by 2
Protection of Novel Adenovirus Vectored Vaccine in Rats Against Wild‐Type Hepacivirus and Variant Infections
Luo, S., Deng, Q., Liang, C., Zhang, P., Zou, P., Deng, S., Zhang, M., Zeng, F., Zhang, L., Fu, Y., et al. (2025) · Liver International · doi:10.1111/liv.70045 · Cited by 2
From seabed to sickbed: lessons gained from allorecognition in marine invertebrates
Rinkevich, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563685 · Cited by 2
Vaccines for preventing infections in adults with solid tumours
Hirsch, C., Zorger, A.-M., Baumann, M., Park, Y. S., Bröckelmann, P. J., Mellinghoff, S. C., Monsef, I., Skoetz, N., & Kreuzberger, N. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015551.pub2 · Cited by 3
AI in the development of vaccines for emerging and re-emerging diseases
Hernández, R. E. V., Velasteguí, V. G. S., Hernández, D. C. V., Rosero, E. A. R., Teneda, A. C. C., Tufiño, A., Cabezas, F. A. V. D. L. B., Espinoza, G. F. S., Contreras-Vásquez, L. F., & Salazar-Garcés, L. F. (2025) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt2024.1285 · Cited by 2
Current Strategies to Improve Efficiency of Recombinant Subunit Vaccines
Bahar, A. G., & İmamoğlu, E. (2023) · Journal of Infectious Diseases and Epidemiology · doi:10.23937/2474-3658/1510299 · Cited by 1
P-type pilus PapG protein elicits toll-like receptor 2-mediated immune activation during cancer immunotherapy
Zhang, W., Park, H., Yadav, D., An, E., Kim, S.-J., Ryu, D.-Y., Agrawal, R., Ryu, J., Kwak, M., Lee, P. C.-W., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137061 · Cited by 1
Advancing Eco-friendly Biomedicine: Sustainable Nanocomposites as Platforms for Genetic Vaccines
Hamidi, A., & Poudineh, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-79110-9_11 · Cited by 2
The spike 486 site is a key immune evasion point and a determinant of the immunogenicity of the RBD-dimer mRNA vaccine against SARS-CoV-2 variants
Feng, S., Huang, M., Quan, Y., Sun, L., Lin, J., Zhang, D., Wei, X., Wang, Z., Ma, X., Wang, S., et al. (2025) · Virology · doi:10.1016/j.virol.2025.110612 · Cited by 1
Multi Epitope Based Vaccine Design against Capnocytophaga canimorsus through Immunoinformatics Approaches
Çavaş, L., & Vatansever, A. (2025) · Bulletin of Biotechnology · doi:10.51539/biotech.1702926 · Cited by 1
Esterase-triggered morphology and charge variable lipid nanoparticles enhance mRNA delivery and synergistically boost immune response
He, Y., Huang, C., Ma, R., Xu, Y., Zheng, Y., Yang, X., Zhang, Y., Chen, J., Yan, P., Ma, Y., et al. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.114456 · Cited by 1
Integrated Analytical Techniques to Investigate the Effect of the Freezing/Thawing Cycles on the Non-replicating Recombinant Chimpanzee Adenovirus Viral Vector COVID-19 Vaccine
Mostafa, M. M., AbdelAllah, N. H., Elzanfaly, E. S., & Sedik, G. A. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03220-6 · Cited by 2
A simple epoxide modification strategy to construct amino-functional poly(2-oxazoline) mRNA delivery vectors
Lv, K., Qi, Y., Zhao, H., Zhang, Y., An, Z., Ma, S., & Song, W. (2025) · Chemical Science · doi:10.1039/d5sc04801j · Cited by 1
Polymer-Functionalized Liposomes as Universal Nanocarriers for Drug Delivery: Single Particle Insights on Size-Dependent Performance and Intracellular Behavior
Voutyritsa, E., Oikonomou, A., Bolis, G., Papageorgiou, V., Vougiatzi, A. S., & Hatzakis, N. S. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c16748 · Cited by 2
Viral evolution in the cosmos
Trovão, N. S., Lucaci, A. G., Pradeep, N., Sethi, M., Bono, L. M., Singh, R. S., Clark, K. B., Zaksas, V., Burke, M., Caicedo, A., et al. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32904-3.00009-1 · Cited by 1
Advances in bioinformatics: Integration of biomolecular simulations and virtual reality for revolutionizing disease mechanism elucidation and therapeutic development
Parikesit, A. A., Ansori, A. N. M., Kharisma, V. D., Purnobasuki, H., & Nugraha, Y. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.11.004 · Cited by 1
Overview of Types of Vaccines and Vaccination Methods
Chuah, J. J., & Parasuraman, S. (2025) · JAP Academy Journal · doi:10.4103/japaj.japaj_19_25 · Cited by 1
Global landscape of mRNA vaccine clinical trials: a systematic analysis of ClinicalTrials.gov data
Liu, S., Zhou, T., Wang, M., Xiang, W., & Wu, J. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1738942 · Cited by 1
Revolutionizing Antimicrobial Resistance
Ahmad, M. N., Ahmad, S. S., & Qureshi, A. M. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-3825-5.ch013 · Cited by 1
Amphiphilic Chitosan–PEI Hybrid Nanocarrier Enhances Delivery Efficiency and Immunogenicity of PEDV mRNA Vaccines
Xu, S., Zhong, H., Li, L., Chen, Y., Sun, C., Lao, Z., Wang, A., Qian, T., Wang, X., & Zhao, K. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s514056 · Cited by 1
In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV-2 using immunoinformatics
Zheng, N., & Xu, Y. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013517 · Cited by 1
An integrated AI-driven vaccine design process: a systematic review of workflows from generative design to translational prediction
Shafaati, M., Jamnani, F. N., & Ghorbani, M. (2026) · Immunologic Research · doi:10.1007/s12026-026-09763-5 · Cited by 2
A Modular Mechanistic In Silico Model for In Vitro Transcription Process Yield and Product Quality Prediction
Wang, K., Choy, K., Reiser, E., Pei, J., Zheng, H., Dasgupta, A., Cheng, F., Dong, G., Mulukutla, B. C., Mannheimer, J., et al. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70222 · Cited by 2
Antigen-delivering biomaterials for local enrichment and reprogramming of immune cells
Wheeler, S. N., & Morris, A. H. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115042 · Cited by 1
Comparative Effectiveness of mRNA-1273 Versus Protein-Based NVX-CoV2705 Vaccination on COVID-19-Related Outcomes Among Insured Adults in the United States During 2024–2025: A Retrospective Matched Cohort Study
Wilson, A., Beck, E. C., Hensler, H. R., Vicic, N., Joshi, K., Patry, E. J., Li, L., Wang, J., & Clarke, C. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03650-z · Cited by 1
Supramolecular STING‐Hydrogel Spatiotemporally Boosts Tumor‐Derived Extracellular Vesicle‐Based Personalized Vaccine for Enhanced Cancer Immunotherapy
Tang, M., Jiang, C., Guo, M., Chen, Q. F., Shang, Q., Xiong, L., Zhang, W., Dong, L., Yue, Q., Gao, X., et al. (2026) · Advanced Materials · doi:10.1002/adma.74204 · Cited by 1
Synergistic co-delivery approaches for next-generation mRNA cancer immunotherapy
Khan, M. K., Hussain, I., Jiahui, L., Zimeng, L., Chenqi, J., Yuxin, Y., Tingyi, Y., Ke, D., Khalil, M. I. K., Hussain, Z., et al. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100928 · Cited by 1
Drivers for Changes in the Evidence Generating Network for Biopharmaceuticals: The Impact of the COVID Pandemic
Wee, C., & Mahn, M. (2022) · Management for professionals · doi:10.1007/978-3-030-98764-0_10 · Cited by 1
Sentiment Classification of Indonesian Emotion Related to Vaccination Event using LSTM
Alfat, L., Nasucha, M., Uddin, N., Salleh, K. A., & Baharun, N. (2023) · IEEE World AI IoT Congress (AIIoT) · doi:10.1109/aiiot58121.2023.10174581 · Cited by 1
Intranasal and Inhaled Vaccines
Chow, M. Y. T., & Lam, J. K. W. (2023) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-47567-2_6 · Cited by 1
Viral genomics
Mahmoud, S. H., & Khalil, A. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18866-4.00002-x · Cited by 1
Integration of Immunology in a Systems-Based Osteopathic Medical Curriculum
Shabbir, Z., Mazdeyasnan, L., Iqbal, N., Kadavakollu, S., Qureshi, M. H., & Lamichhane-Khadka, R. (2024) · International Medical Education · doi:10.3390/ime3030021 · Cited by 1
Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Mycobacterium tuberculosis Preferentially Elicited CD8+ T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice than Bacillus Calmette–Guerin
Wang, L., Kang, J., & Jiang, H. X. (2024) · Vaccines · doi:10.3390/vaccines12091022 · Cited by 1
Particle adjuvants for vaccines
Liu, H., Zhang, Y., Yue, H., & Ma, G. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1171 · Cited by 1
The Application of DNA Viruses to Biotechnology
Schieferecke, A. J., Ralph, N. K., & Schaffer, D. V. (2025) · Viruses · doi:10.3390/v17030414 · Cited by 2
Structural Insights into Minor and Core Proteins of Bovine Adenovirus 3: Bridging Capsid and Genomic Core
Xiao, H. J., Pang, H., Zhou, J., Feng, H., Song, J., Cheng, L., Wang, L., & Liu, H. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169208 · Cited by 1
COVID-19: Not just another respiratory virus—2020
Tizard, I. R., & Musser, J. M. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98925-1.00010-6 · Cited by 1
COVID- e Vax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19Preprint
Conforti, A., Marra, E., Palombo, F., Roscilli, G., Ravà, M., Fumagalli, V., Muzi, A., Maffei, M., Luberto, L., Lione, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.14.448343 · Cited by 2
The path to anti-vector vaccines: current advances and limitations in proteomics and bioinformatics
Sobrino, I., Villar, M., & de la Fuente, J. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2438792 · Cited by 1
Current State of mRNA Vaccine Development Against Mycobacterium tuberculosis
Aernout, I., Verbeke, R., Smedt, S. C. D., Impens, F., & Lentacker, I. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch12 · Cited by 1
Systemic trafficking of mRNA lipid nanoparticle vaccine following intramuscular injection generates potent tissue-specific T cell responsePreprint
Wei, C. Y., Zhu, Y., Lu, X., Goodier, K. D., Yu, D., Liu, X., Choy, J., Calderón, A. T., Ma, J., Su, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.21.649878 · Cited by 1
Genetically Modified Viral Vectors for Vaccine Delivery
Arora, D., Taneja, Y., Gulati, D., Kumar, M., Pareek, A., & Gautam, R. K. (2025) · Wiley eBooks · doi:10.1002/9781394271566.ch6 · Cited by 1

Authors: Gebre, M. S., Brito, L. A., Tostanoski, L. H., Edwards, D. K., Carfi, A., & Barouch, D. H.
Affiliations: Beth Israel Deaconess Medical Center (US)
Moderna Therapeutics (United States) (US)
Corresponding author: Barouch, Dan H.
ORCID: Gebre, Makda S.
Tostanoski, Lisa H.
Edwards, Darin K.
Barouch, Dan H.
Venue: Cell
Publisher: Elsevier BV
Published: 2021-03
Volume: 184
Issue: 6
Pages: 1589-1603
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2021.02.030
PMC: PMC8049514
OpenAlex: W3137746616
Cited by: 347
References: 151
Citations by year: 2026: 42 · 2025: 92 · 2024: 72 · 2023: 55 · 2022: 63 · 2021: 21
FWCI: 5.41
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 383 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (U01CA260476)
National Institute of Allergy and Infectious Diseases (U19AI128751, T32AI007387)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: vaccine development, RNA vaccines, nucleic acid vaccines, viral vector vaccines, recombinant adenovirus vector, persistent infection, emerging pathogens, biomaterials
MeSH terms: Immunogenicity, Vaccine, COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, Adenoviridae, Animals, Antigens, Viral, Biocompatible Materials, Genetic Vectors, Humans, Liposomes, RNA, Messenger, Vaccines, Synthetic, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Novel approaches for vaccine development

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks